Skip to main content
. 2020 Jul 23;15:278. doi: 10.1186/s13018-020-01803-6

Table 2.

Kaplan–Meier analysis overall survival for chordoma patients

Characteristic 5-year overall survival, % 10-year overall survival, % Median overall survival (months) Kaplan-Meier
Log rank χ2 test p value
Age at diagnosis 164.433 < 0.001
 < 40 83.8 74.4
 40–60 82.8 58.7 138.0
 > 60 54.3 25.2 68.0
Sex 2.585 0.108
 Male 70.5 45.9 105.0
 Female 72.9 52.0 132.0
Marital status 66.240 < 0.001
 Married 73.7 51.5 125.0
 Divorced/separated 69.5 42.8 103.0
 Widowed 45.2 12.5 56.0
 Single 75.6 57.0 157.0
Primary site 41.055 < 0.001
 Bones of skull and face and associated joints 79.2 65.1 253.0
 Vertebral column 66.7 37.9 90.0
 Pelvic bone, sacrum, coccyx, and associated joints 66.4 40.1 91.0
Disease stage 29.554 < 0.001
 Localized 77.6 55.3 147.0
 Regional 71.6 48.2 105.0
 Distant 49.7 32.7 53.0
 Unstaged 65.2 39.0 89.0
Tumor size 45.181 < 0.001
 < 5 cm 82.3 70.9 243.0
 5–10 cm 70.5 45.9 106.0
 > 10 cm 55.9 32.1 70.0
 Unknown 67.0 41.0 94.0
Histological type 12.265 0.002
 Conventional chordoma 71.5 47.6 110.0
 Chondroid chordoma 76.6 72.8 -
 Dedifferentiated chordoma 28.6 28.6 14.0
Surgery 97.790 < 0.001
 Surgery not performed 48.3 26.0 56.0
 STR 78.1 58.5 154.0
 GTR 82.9 59.3 178.0
 Unknown extent of resection 59.1 31.9 80.0
Radiotherapy 0.140 0.708
 Yes 72.7 47.1 106.0
 No 70.0 49.7 120.0
Chemotherapy 11.445 0.001
 Yes 47.9 28.1 51.0
 No 72.4 49.4 119.0

Note: p value < 0.05 are shown in bold

Abbreviations: STR subtotal resection, GTR gross total/radical resection